DOHMOTO Hideki | Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
スポンサーリンク
概要
関連著者
-
DOHMOTO Hideki
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
YOSHIMOTO Ryota
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc.
-
Dohmoto Hideki
Pharmaceutical Research Laboratories Pharmaceuticals Company Ajinomoto Co. Inc.
-
Yoshimoto Ryota
Pharmaceutical Research Laboratories Pharmaceuticals Company Ajinomoto Co. Inc.
-
Aikawa Tokiko
Department Of Pharmacology Toho University Faculty Of Pharmaceutical Sciences
-
Yoshimoto Ryota
Pharmaceutical Research Laboratories Ajinomoto Co. Inc.
-
Takahara Akira
Pharmaceutical Research Laboratories Ajinomoto Co. Inc.
-
Dohmoto Hideki
Life Science Laboratories Central Research Laboratories Ajinomoto Co. Inc.:pharmaceuticals Research
-
Sugiyama Atsushi
Department Of Pharmacology Yamanashi Medical University
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
著作論文
- In Vivo Antiarrhythmic Profile of AP-792 Assessed in Different Canine Arrhythmia Models
- In Vitro and ex Vivo Ca-Antagonistic Effect of 2-Methoxyethyl (E)-3-phenyl-2-propen-1-yl (±)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate (FRC-8653), a New Dihydropyridine Derivative
- Cardiac Ca^ Channel-Blocking Effects of the Cyproheptadine Derivative AH-1058 in Isolated Guinea Pig Cardiomyocytes
- 1050 INHIBITORY EFFECTS OF CILNIDIPINE, A DHP CALCIUM ANTAGONIST, ON NOREPINEPHRINE RELEASE AND N-TYPE CALCIUM CURRENTS
- Utilization of Telemetry System to Assess the Cardiovascular Profile of AH-1058, a New Cardioselective Ca^ Channel Blocker, in Conscious Dogs
- Electrophysiological and Cardiohemodynamic Effects of AH-1058, a New Type Calcium Channel Blocker, Assessed by the In Vivo Canine Model
- Cilnidipine Attenuates Renal Nerve Stimulation-Induced Renal Vasoconstriction and Antinatriuresis in Anesthetized Dogs